Document is current
Any future updates will be listed below
-
Authors
Finer, Nick https://orcid.org/0000-0003-2468-6804
- License Information
-
More Information
Article History
Received: 3 July 2025
Revised: 22 August 2025
Accepted: 22 August 2025
First Online: 30 August 2025
Competing interests
: Paid consultancy and lectures: Novo Nordisk, Yazen, Alveus Therapeutics, Eva Pharma. Unremunerated positions with registered charities: Chair Publications Committee, World Obesity Federation; President International Prader Willi Syndrome Association.
Free to read: This content has been made available to all.
